VEGFA and renal cell carcinoma: Recently, cytokine-induced killer cells, VEGF monoclonal antibodies like Bevacizumab, and immune checkpoint inhibitors like PD1/PDL1 inhibitors have been widely used in the treatment of advanced RCC.